| SOSTANZE D'ABUSO |
| |
|
DIPENDENZA, TOLLERANZA, ASTINENZA PARTE 4
|
|
Aguirre N, Barrionuevo M, Lasheras B, Del Rio J. The role of dopaminergic
systems in the perinatal sensitivity to 3,4-methylenedioxymethamphetamine-induced neurotoxicity in rats. J Pharmacol Exp
Ther 1998 Sep;286(3):1159-65
Ameri A. The effects of cannabinoids on the brain. Prog Neurobiol 1999
Jul;58(4):315-48
Bassareo V, Di Chiara G Differential responsiveness of dopamine transmission to
food-stimuli in nucleus accumbens shell/core compartments. Neuroscience 1999
Mar;89(3):637-41
Battaglia G, Napier TC. The effects of cocaine and the amphetamines on brain and
behavior: a conference report. Drug Alcohol Depend 1998 Sep 1;52(1):41-8
Bilsky EJ, Hui YZ, Hubbell CL, Reid LD. Methylenedioxymethamphetamine's capacity
to establish place preferences and modify intake of an alcoholic beverage.
Pharmacol Biochem Behav 1990 Dec;37(4):633-8
Blum K, Braverman ER, Holder JM, Lubar JF, Monastra VJ, Miller D, Lubar JO, Chen
TJ, Comings DE. Reward deficiency syndrome: a biogenetic model for the diagnosis
and treatment of impulsive, addictive, and compulsive behaviors. J Psychoactive
Drugs 2000 Nov;32 Suppl:i-iv, 1-112
Borgland SL. Acute opioid receptor desensitization and tolerance: is there a
link? Clin Exp Pharmacol Physiol 2001 Mar;28(3):147-54
Boyadjieva N, Sarkar DK. Effects of ethanol on basal and adenosine-induced
increases in beta-endorphin release and intracellular cAMP levels in
hypothalamic cells. Brain Res 1999 Apr 3;824(1):112-8
Brase DA. Is intracellular sodium involved in the mechanism of tolerance to
opioid drugs? Med Hypotheses 1990 Jul;32(3):161-7
Buydens-Branchey L, Branchey M, Fergeson P, Hudson J, McKernin C. The
meta-chlorophenylpiperazine challenge test in cocaine addicts: hormonal and
psychological responses. Biol Psychiatry 1997 Jun 1;41(11):1071-86
Cadogan AK, Alexander SP, Boyd EA, Kendall DA. Influence of cannabinoids on
electrically evoked dopamine release and cyclic AMP generation in the rat
striatum. J Neurochem 1997 Sep;69(3):1131-7
Camarini R, Frussa-Filho R, Monteiro MG, Calil HM. MK-801 blocks the development
of behavioral sensitization to the ethanol. Alcohol Clin Exp Res 2000
Mar;24(3):285-90
Capasso A. Further studies on the involvement of the arachidonic acid cascade in
the acute dependence produced by mu, kappa and delta opioid agonists in isolated
tissues. Neuropharmacology 1999 Jun;38(6):871-7
Carr KD, Kutchukhidze N, Park TH. Differential effects of mu and kappa opioid
antagonists on Fos-like immunoreactivity in extended amygdala. Brain Res 1999
Mar 20;822(1-2):34-42
Chang L, Grob CS, Ernst T, Itti L, Mishkin FS, Jose-Melchor R, Poland RE. Effect
of ecstasy [3,4-methylenedioxymethamphetamine (MDMA)] on cerebral blood flow: a
co-registered SPECT and MRI study. Psychiatry Res 2000 Feb 28;98(1):15-28
Chaperon F, Thiebot MH. Behavioral effects of cannabinoid agents in animals.
Crit Rev Neurobiol 1999;13(3):243-81
Christie MJ, Williams JT, Osborne PB, Bellchambers CE. Where is the locus in
opioid withdrawal? Trends Pharmacol Sci 1997 Apr;18(4):134-40
Collin E, Cesselin F. Neurobiological mechanisms of opioid tolerance and
dependence. Clin Neuropharmacol 1991 Dec;14(6):465-88
Comings DE, Blum K. Reward deficiency syndrome: genetic aspects of behavioral
disorders. Prog Brain Res 2000;126:325-41
Corrigall WA, Coen KM, Adamson KL, Chow BL. Manipulations of mu-opioid and
nicotinic cholinergic receptors in the pontine tegmental region alter cocaine
self-administration in rats. Psychopharmacology (Berl) 1999 Aug;145(4):412-7
Corrigall WA, Coen KM, Adamson KL. Self-administered nicotine activates the
mesolimbic dopamine system through the ventral tegmental area. Brain Res 1994
Aug 8;653(1-2):278-84
Cowen MS, Lawrence AJ. The role of opioid-dopamine interactions in the induction
and maintenance of ethanol consumption. Prog Neuropsychopharmacol Biol
Psychiatry 1999 Oct;23(7):1171-212
Davidson C, Ellinwood EH, Lee TH. Altered sensitivity of dopamine autoreceptors
in rat accumbens 1 and 7 days after intermittent or continuous cocaine
withdrawal. Brain Res Bull 2000 Jan 1;51(1):89-93
Di Marzo V, Hill MP, Bisogno T, Crossman AR, Brotchie JM. Enhanced levels of
endogenous cannabinoids in the globus pallidus are associated with a reduction
in movement in an animal model of Parkinson's disease. FASEB J 2000
Jul;14(10):1432-8
Friedman LK, Gibbs TT, Farb DH. gamma-aminobutyric acidA receptor regulation:
heterologous uncoupling of modulatory site interactions induced by chronic
steroid, barbiturate, benzodiazepine, or GABA treatment in culture. Brain Res
1996 Jan 22;707(1):100-9
Gerra G, Marcato A, Caccavari R, Fontanesi B, Delsignore R, Fertonani G,
Avanzini P, Rustichelli P, Passeri M. Clonidine and opiate receptor antagonists
in the treatment of heroin addiction. J Subst Abuse Treat 1995
Jan-Feb;12(1):35-41
Gerra G, Zaimovic A, Rustichelli P, Fontanesi B, Zambelli U, Timpano M, Bocchi
C, Delsignore R. Rapid opiate detoxication in outpatient treatment: relationship
with naltrexone compliance. J Subst Abuse Treat 2000 Mar;18(2):185-91
Gianoulakis C, de Waele JP, Thavundayil J. Implication of the endogenous opioid
system in excessive ethanol consumption. Alcohol 1996 Jan-Feb;13(1):19-23
Giuffrida A, Parsons LH, Kerr TM, Rodriguez de Fonseca F, Navarro M, Piomelli D.
Dopamine activation of endogenous cannabinoid signaling in dorsal striatum. Nat
Neurosci 1999 Apr;2(4):358-63
Gold MS, Redmond DE Jr, Kleber HD. Noradrenergic hyperactivity in opiate
withdrawal supported by clonidine reversal of opiate withdrawal. Am J Psychiatry
1979 Jan;136(1):100-2
Gold, Mark S. Cocaine (and Crack): Clinical Aspects (181-198), Substance Abuse:
A Comprehensive Textbook, Third Edition, Lowinson, ed. Baltimore, MD: Williams
& Wilkins, 1997.
Gomes I, Jordan BA, Gupta A, Trapaidze N, Nagy V, Devi LA. Heterodimerization of
mu and delta opioid receptors: A role in opiate synergy. J Neurosci 2000 Nov
15;20(22):RC110
Griffiths RR, Evans SM, Guarino JJ, Roache JD, Furman WR, Liebson I, Schwam EM.
Intravenous flumazenil following acute and repeated exposure to lorazepam in
healthy volunteers: antagonism and precipitated withdrawal. J Pharmacol Exp Ther
1993 Jun;265(3):1163-74
Hammer RP Jr, Egilmez Y, Emmett-Oglesby MW. Neural mechanisms of tolerance to
the effects of cocaine. Behav Brain Res 1997 Mar;84(1-2):225-39
Haney M, Gerra G, Fischman MW, Foltin RW Neuroendocrine effects of
d-fenfluramine after repated cocaine self-administration in humans. In press
Drug Alcohol Depend.
Harvey, John A. and Kosofsky, Barry, eds. Cocaine: Effects on the Developing
Brain. Annals of the New York Academy of Sciences, Volume 846, 1998.
Herz A. Endogenous opioid systems and alcohol addiction. Psychopharmacology
(Berl) 1997 Jan;129(2):99-111
Hughes JR. Why does smoking so often produce dependence? A somewhat different
view. Tob Control 2001 Mar;10(1):62-4
Hunt WA. The effect of ethanol on GABAergic transmission. Neurosci Biobehav Rev
1983 Spring;7(1):87-95
Jones KL, Barr GA. Injections of an opioid antagonist into the locus coeruleus
and periaqueductal gray but not the amygdala precipitates morphine withdrawal in
the 7-day-old rat. Synapse 2001 Feb;39(2):139-51
Jordan BA, Cvejic S, Devi LA. Opioids and their complicated receptor complexes.
Neuropsychopharmacology 2000 Oct;23(4 Suppl):S5-S18
Kilts CD, Schweitzer JB, Quinn CK, Gross RE, Faber TL, Muhammad F, Ely TD,
Hoffman JM, Drexler KP. Neural activity related to drug craving in cocaine
addiction. Arch Gen Psychiatry 2001 Apr;58(4):334-41
King GR, Xiong Z, Douglass S, Ellinwood EH. Long-term blockade of the expression
of cocaine sensitization by ondansetron, a 5-HT(3) receptor antagonist. Eur J
Pharmacol 2000 Apr 7;394(1):97-101
Kleber HD, Topazian M, Gaspari J, Riordan CE, Kosten T. Clonidine and naltrexone
in the outpatient treatment of heroin withdrawal. Am J Drug Alcohol Abuse
1987;13(1-2):1-17
Klein RL, Whiting PJ, Harris RA. Benzodiazepine treatment causes uncoupling of
recombinant GABAA receptors expressed in stably transfected cells. J Neurochem
1994 Dec;63(6):2349-52
Koff JM, Pritchard GA, Greenblatt DJ, Miller LG. The NMDA receptor competitive
antagonist CPP modulates benzodiazepine tolerance and discontinuation.
Pharmacology 1997 Nov;55(5):217-27
Koob GF, Roberts AJ, Schulteis G, Parsons LH, Heyser CJ, Hyytia P, Merlo-Pich E,
Weiss F. Neurocircuitry targets in ethanol reward and dependence. Alcohol Clin
Exp Res 1998 Feb;22(1):3-9
Kreek MJ. Cocaine, dopamine and the endogenous opioid system. J Addict Dis
1996;15(4):73-96
Laorden ML, Fuertes G, Gonzalez-Cuello A, Milanes MV. Changes in
catecholaminergic pathways innervating paraventricular nucleus and
pituitary-adrenal axis response during morphine dependence: implication of
alpha(1)- and alpha(2)-adrenoceptors. J Pharmacol Exp Ther 2000
May;293(2):578-84
Lee TH, Gao WY, Davidson C, Ellinwood EH. Altered activity of midbrain dopamine
neurons following 7-day withdrawal from chronic cocaine abuse is normalized by
D2 receptor stimulation during the early withdrawal phase.
Neuropsychopharmacology 1999 Jul;21(1):127-36
Li XW, Li TK, Froehlich JC. Enhanced sensitivity of the nucleus accumbens
proenkephalin system to alcohol in rats selectively bred for alcohol preference.
Brain Res 1998 May 25;794(1):35-47
Liaw WJ, Ho ST, Wang JJ, Wong CS, Lee HK. Cellular mechanism of opioid tolerance
Acta Anaesthesiol Sin 1996 Dec;34(4):221-34
Liechti ME, Vollenweider FX. The serotonin uptake inhibitor citalopram reduces
acute cardiovascular and vegetative effects of 3,4-methylenedioxymethamphetamine
('Ecstasy') in healthy volunteers. J Psychopharmacol 2000;14(3):269-74
Little KY, Kirkman JA, Carroll FI, Clark TB, Duncan GE. Cocaine use increases
[3H]WIN 35428 binding sites in human striatum. Brain Res 1993 Nov
19;628(1-2):17-25
Little KY, Zhang L, Desmond T, Frey KA, Dalack GW, Cassin BJ. Striatal
dopaminergic abnormalities in human cocaine users. Am J Psychiatry 1999
Feb;156(2):238-45
Manzanares J, Corchero J, Fuentes JA. Opioid and cannabinoid receptor-mediated
regulation of the increase in adrenocorticotropin hormone and corticosterone
plasma concentrations induced by central administration of
delta(9)-tetrahydrocannabinol in rats. Brain Res 1999 Aug 21;839(1):173-9
Marinelli M, Barrot M, Simon H, Oberlander C, Dekeyne A, Le Moal M, Piazza PV.
Pharmacological stimuli decreasing nucleus accumbens dopamine can act as
positive reinforcers but have a low addictive potential. Eur J Neurosci 1998
Oct;10(10):3269-75
Matell MS, King GR. 5-HT3 receptor mediated dopamine release in the nucleus
accumbens during withdrawal from continuous cocaine. Psychopharmacology (Berl)
1997 Apr;130(3):242-8
Miller RT, Lau SS, Monks TJ. Effects of intracerebroventricular administration
of 5-(glutathion-S-yl)-alpha-methyldopamine on brain dopamine, serotonin, and
norepinephrine concentrations in male Sprague-Dawley rats. Chem Res Toxicol 1996
Mar;9(2):457-65
Mirovsky Y, Wagner GC, Sekowski A, Goldberg M, Fisher H. Simultaneous changes in
striatal dopamine, serotonin, and metabolites after withdrawal seizures in rats
from dependence on alcohol. Alcohol 1995 May-Jun;12(3):251-6
Narita M, Aoki T, Ozaki S, Yajima Y, Suzuki T. Involvement of protein kinase
Cgamma isoform in morphine-induced reinforcing effects. Neuroscience
2001;103(2):309-14
Nevo I, Hamon M. Neurotransmitter and neuromodulatory mechanisms involved in
alcohol abuse and alcoholism. Neurochem Int 1995 Apr;26(4):305-36
Paladini CA, Fiorillo CD, Morikawa H, Williams JT. Amphetamine selectively
blocks inhibitory glutamate transmission in dopamine neurons. Nat Neurosci 2001
Mar;4(3):275-81
Paul ML, Currie RW, Robertson HA. Priming of a D1 dopamine receptor behavioural
response is dissociated from striatal immediate-early gene activity.
Neuroscience 1995 May;66(2):347-59
Pelissolo A. The benzodiazepine receptor: the enigma of the endogenous ligand.
Encephale 1995 Mar-Apr;21(2):133-40
Piepponen TP, Honkanen A, Kivastik T, Zharkovsky A, Turtia A, Mikkola JA, Ahtee
L. Involvement of opioid mu1-receptors in opioid-induced acceleration of
striatal and limbic dopaminergic transmission. Pharmacol Biochem Behav 1999
Jun;63(2):245-52
Rommelspacher H, Schmidt LG, Helmchen H. Pathobiochemistry and pharmacotherapy
of alcohol withdrawal delirium. Nervenarzt 1991 Nov;62(11):649-57
Rose JE, Corrigall WA. Nicotine self-administration in animals and humans:
similarities and differences. Psychopharmacology (Berl) 1997 Mar;130(1):28-40
Sala M, Braida D, Colombo M, Groppetti A, Sacco S, Gori E, Parenti M. Behavioral
and biochemical evidence of opioidergic involvement in cocaine sensitization. J
Pharmacol Exp Ther 1995 Jul;274(1):450-7
Singewald N, Philippu A. Release of neurotransmitters in the locus coeruleus.
Prog Neurobiol 1998 Oct;56(2):237-67
Spyraki C, Fibiger HC, Phillips AG. Attenuation of heroin reward in rats by
disruption of the mesolimbic dopamine system. Psychopharmacology (Berl)
1983;79(2-3):278-83
Tanda G, Loddo P, Di Chiara G. Dependence of mesolimbic dopamine transmission on
delta9-etrahydrocannabinol. Eur J Pharmacol 1999 Jul 2;376(1-2):23-6
Tanda G, Pontieri FE, Di Chiara G. Cannabinoid and heroin activation of
mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism.
Science 1997 Jun 27;276(5321):2048-50
Tokuyama S, Takahashi M, Yamamoto T. On the role of glutamate within the locus
coeruleus during the development of opioid dependence and on the expression of
withdrawal from dependence on opioids. Nihon Shinkei Seishin Yakurigaku Zasshi
2000 Oct;20(4):141-7
Tokuyama S, Zhu H, Oh S, Ho IK, Yamamoto T. Further evidence for a role of NMDA
receptors in the locus coeruleus in the expression of withdrawal syndrome from
opioids. Neurochem Int 2001 Aug;39(2):103-9
Tran-Nguyen LT, Fuchs RA, Coffey GP, Baker DA, O'Dell LE, Neisewander JL.
Time-dependent changes in cocaine-seeking behavior and extracellular dopamine
levels in the amygdala during cocaine withdrawal. Neuropsychopharmacology 1998
Jul;19(1):48-59
Ujike H. Advanced findings on the molecular mechanisms for behavioral
sensitization to psychostimulants. Nippon Yakurigaku Zasshi 2001
Jan;117(1):5-12
Ungless MA, Whistler JL, Malenka RC, Bonci A. Single cocaine exposure in vivo
induces long-term potentiation in dopamine neurons. Nature 2001 May
31;411(6837):583-7
Unterwald EM, Ho A, Rubenfeld JM, Kreek MJ. Time course of the development of
behavioral sensitization and dopamine receptorup-regulation during binge cocaine
administration. J Pharmacol Exp Ther 1994 Sep;270(3):1387-96
Volkow ND, Ding YS, Fowler JS, Wang GJ. Cocaine addiction: hypothesis derived
from imaging studies with PET. J Addict Dis 1996;15(4):55-71
Wang JJ, Ho ST. Acute and chronic opioid tolerance: a pharmacological review.
Acta Anaesthesiol Sin 1994 Dec;32(4):261-7
Ward AS, Collins ED, Haney M, Foltin RW, Fischman MW. Ketoconazole attenuates
the cortisol response but not the subjective effects of smoked cocaine in
humans. Behav Pharmacol 1998 Nov;9(7):577-86
Wardlaw SL, Kim J, Sobieszczyk S. Effect of morphine on proopiomelanocortin gene
expression and peptide levels in the hypothalamus. Brain Res Mol Brain Res 1996
Sep 5;41(1-2):140-7
Welch SP, Eads M. Synergistic interactions of endogenous opioids and cannabinoid
systems. Brain Res 1999 Nov 27;848(1-2):183-90
|
|
| Primo Piano Dipartimento Politiche Antidroga
Presidenza del Consiglio dei Ministri |
- Principi generali della posizione italiana contro l’uso di droghe ( IT, EN)
- Accordo di collaborazione scientifica Italia-USA ( IT, EN)
- Dichiarazione DPA collaborazioni scientifiche internazionali ( IT, EN) |
|
|
|
| Oggi i giornali parlano di droga |
|
|
|
